Talk:LigoLab

LigoLab Source Analysis

Source	In-Depth	Reliable	Comments
https://www.darkdaily.com/laboratory-resources-2/revenue-cycle-systems-and-services/ligolab-information-system/	YES	YES	Article from a reliable Clinical lab publication that posts news and reviews Lab related companies. This is a very long review and definitely considered significant coverage.
https://www.medlabmag.com/article/1687	YES	YES	Peer review website
https://www.captodayonline.com/newsbytes-1120/	YES	YES	This is a very vey in-depth article. Contains a few quotations, but they are less than 5% of the overall content.
https://www.mlo-online.com/information-technology/lis/article/21132383/ligolab-provides-its-lis-at-no-cost-to-labs-implementing-covid19-testing	YES	YES	This is an in-dept article.
https://medcitynews.com/2021/08/molecular-labs-hold-the-key-to-evidence-based-precision-medicine/	NO	YES	One paragraph info about them + 2 quotations
https://www.capterra.com/p/95392/LigoLab-Station/	YES	YES	This is a business software review site. It has a very in-depth review. There are no affiliate links.
https://www.modernhealthcare.com/supply-chain/covid-driving-labs-build-out-information-systems	YES	YES	Not entirely about LigoLab, but has at least 5 paragraphs of info about them, so it's not a passing mention.
https://www.360dx.com/clinical-lab-management/telehealth-space-expands-companies-move-secure-lab-capabilities#.YlTSx8jMIuW	NO	YES	2 Paragraphs of info about the company. It is behind a paywall, but if you view source code and search for Ligolab, you will find the relevant sections.
https://www.inc.com/profile/ligolab-information-systems	NO	YES	Not much info here, but making it to Inc5000 is significant in itself for notability. it is a major award.
https://clpmag.com/disease-states/infectious-diseases/covid-19/testdirectly-web-portal-simplifies-workflows-improves-turnaround-times/	YES	YES	in-depth Article
https://clpmag.com/disease-states/infectious-diseases/covid-19/florida-to-test-all-of-the-states-long-term-care-residents-and-staff-for-covid-19/	YES	YES	In-depth coverage and very significant. Couple of quotations exist, but they are less than 10% of the total article.
https://clpmag.com/disease-states/infectious-diseases/covid-19/lab-detects-uk-covid-19-variant-with-pcr-test-confirmed-with-rna-sequencing/	NO	YES	Not entirely about Ligolab, but has a couple of sections of info about them.
https://www.aacc.org/cln/articles/2021/november/the-lab-is-moving-from-a-black-box-to-a-smartphone-app	YES	YES	4 paragraphs of info on Liglab, one paragraph is a quote. I would consider 3 paragraphs or more to be significant and not a passing mention.
https://clpmag.com/lab-essentials/information-technology/ligolabs-lis-and-rcm-maximizes-clean-claims-lab-payments/	Maybe	YES	220 Words info about them. Not a passing mention.
https://medcitynews.com/2021/02/how-text-messaging-is-transforming-the-life-sciences-industry/	NO	YES	3 paragraphs info, one paragraph a quotation. I would not call it in-depth
https://www.darkintelligencegroup.com/the-dark-report/laboratory-management/pathology-lab-transforms-runs-1m-covid-19-tests/	NO	YES	Passing mention

Johnmclane2 (talk) 02:12, 12 April 2022 (UTC)

Thanks for putting this together. I wouldn't say this is compelling because it is mostly trade publication coverage. It is enough for me to accept the article. There is still a chance someone else will want to try to delete it. We'll see what happens. ~Kvng (talk) 03:46, 29 July 2022 (UTC)